Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma BiomarkersNiklas Mattsson, Oskar Hansson, Sterling C. Johnson et al.|JAMA Neurology|2023Cited by 293
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive ImpairmentShorena Janelidze, Oskar Hansson, Nicolas R. Barthélemy et al.|JAMA Neurology|2024Cited by 109
Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologiesAlexa Pichet Binette, Oskar Hansson, Chris Gaiteri et al.|Nature Neuroscience|2024Cited by 107
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker testsNoëlle Warmenhoven, Oskar Hansson, Gemma Salvadó et al.|Brain|2024Cited by 95
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer’s disease spectrumJaime Fernández Arias, Pedro Rosa‐Neto, Wagner S. Brum et al.|Brain|2025Cited by 22